Retrieve available abstracts of 21 articles: HTML format
Single Articles
September 2025
LIU H, Zou Z, Zhang L Reply to 'Comments on "HPV vaccination is highly effective and cost-effective for
cervical cancer prevention in women living with HIV in China: A
cost-effectiveness analysis"'.
Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70129. PubMed
LIU Z, Tong X Comments on "HPV vaccination is highly effective and cost-effective for cervical
cancer prevention in women living with HIV in China: A cost-effectiveness
analysis".
Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70130. PubMed
SAEEDI E, Nemati S, Lotfi F, Domingues A, et al IRANCANSURV: A comprehensive analysis of childhood cancer survival in Iran.
Int J Cancer. 2025 Sep 1. doi: 10.1002/ijc.70100. PubMedAbstract available
August 2025
ZHAO J, Zhang Y, Li K, Xu L, et al Estimates of global, regional, and national incidence of Hodgkin lymphoma
attributable to Human Immunodeficiency virus: A population attributable modeling
study.
Int J Cancer. 2025 Aug 29. doi: 10.1002/ijc.70115. PubMedAbstract available
FENG X, Patel EU, Kigozi G, Gravitt PE, et al Longitudinal patterns of penile human papillomavirus detection among Ugandan men:
A prospective sampling study.
Int J Cancer. 2025 Aug 25. doi: 10.1002/ijc.70107. PubMedAbstract available
HAAS CB, Ocampo R, Liu D, Zuniga M, et al Design and initial findings of a natural history study of anal HPV and associated
lesions among young adult women in Costa Rica.
Int J Cancer. 2025 Aug 15. doi: 10.1002/ijc.70082. PubMedAbstract available
LOPES-ARAUJO HF, Guimaraes RL, Carvalho-Silva WHV Correlations between new HIV infections and hospital admissions for non-Hodgkin
lymphoma in Brazil.
Int J Cancer. 2025 Aug 6. doi: 10.1002/ijc.70076. PubMedAbstract available
ROZEMEIJER K, Dias Goncalves Lima F, Kuyvenhoven EJ, de Vries HJC, et al Swab-based anal cancer screening in men living with HIV: Projected outcomes for
different screening algorithms.
Int J Cancer. 2025 Aug 5. doi: 10.1002/ijc.70046. PubMedAbstract available
July 2025
BELLO-PEREZ M, Mascarell P, Fernandez-Gonzalez M, Garcia JA, et al ADAR1 mRNA quantification for predicting HSIL in persons with HIV and abnormal
anal cytology.
Int J Cancer. 2025 Jul 24. doi: 10.1002/ijc.70050. PubMedAbstract available
June 2025
ZHENG Y, Han J, Qu Y, Wang J, et al DNA methylation biomarkers for cervical cancer risk prediction in HIV-positive
Nigerian women.
Int J Cancer. 2025 Jun 9. doi: 10.1002/ijc.35502. PubMedAbstract available
JENKINS M, Saidu R, Boa R, Mbatani N, et al Performance of thermoablation among women treated for high-risk human
papillomavirus in a screen-and-treat program in South Africa.
Int J Cancer. 2025 Jun 6. doi: 10.1002/ijc.35519. PubMedAbstract available
May 2025
PISELLI P, Tavelli A, Cimaglia C, Muccini C, et al Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with
general population data.
Int J Cancer. 2025 May 29. doi: 10.1002/ijc.35493. PubMedAbstract available
February 2025
KEBEDE HB, Mekuria S, Asegid N, Forslund O, et al High-risk human papillomavirus genotypes in previously unscreened
reproductive-age women in Ethiopia: A community-based cohort study.
Int J Cancer. 2025 Feb 14. doi: 10.1002/ijc.35335. PubMedAbstract available
January 2025
NALWOGA A, Jackson C, Fiorillo S, Manyeruke F, et al Evaluation of plasma alpha-1-antichymotrypsin as a marker for pulmonary Kaposi
sarcoma.
Int J Cancer. 2025 Jan 30. doi: 10.1002/ijc.35351. PubMedAbstract available
December 2024
MOTLHALE M, Sitas F, de Villiers CB, Simba H, et al Smokeless tobacco (snuff) and site-specific cancer risks in adult Black South
African women: Findings from the Johannesburg Cancer Study.
Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35293. PubMedAbstract available
November 2024
LIU H, Zou M, Shen M, Kamarulzaman A, et al HPV vaccination is highly effective and cost-effective for cervical cancer
prevention in women living with HIV in China: A cost-effectiveness analysis.
Int J Cancer. 2024 Nov 17. doi: 10.1002/ijc.35242. PubMedAbstract available
September 2024
DEBEAUDRAP P, Kabore FN, Setha L, Tegbe J, et al Performance of visual inspection, partial genotyping, and their combination for
the triage of women living with HIV who are screen positive for human
papillomavirus: Results from the AIMA-CC ANRS 12375 multicentric screening study.
Int J Cancer. 2024 Sep 25. doi: 10.1002/ijc.35190. PubMedAbstract available
August 2024
DUSINGIZE JC, Murenzi G, Muhoza B, Businge L, et al Cancer risk among people living with Human Immuodeficiency Virus (HIV) in Rwanda
from 2007 to 2018.
Int J Cancer. 2024 Aug 11. doi: 10.1002/ijc.35091. PubMedAbstract available
April 2024
VASAVADA A, Stankiewicz Karita HC, Lin J, Schouten J, et al Methylation markers for anal cancer screening: A repeated cross-sectional
analysis of people living with HIV, 2015-2016.
Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34977. PubMedAbstract available
DOWNHAM L, Rol ML, Forestier M, Romero P, et al Field experience with the 8-HPV-type oncoprotein test for cervical cancer
screening among HPV-positive women living with and without HIV in LMICs.
Int J Cancer. 2024 Apr 11. doi: 10.1002/ijc.34953. PubMedAbstract available
SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al Antibodies against high-risk human papillomavirus proteins as markers for
noncervical HPV-related cancers in a Black South African population, according to
HIV status.
Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919. PubMedAbstract available